Categories AlphaGraphs, Earnings, Finance

GNW Earnings: A snapshot of Genworth Financial’s Q1 2023 results

Insurance service provider Genworth Financial, Inc. (NYSE: GNW) has reported lower earnings and revenues for the first quarter of 2023. The company repurchased around $68 million of its stock during the quarter.

Genworth Financial Q1 2023 earnings infographic

Net income available to shareholders decreased to $62 million or $0.12 per share in the March quarter from $191 million or $0.37 per share in the prior-year period.

The bottom line was negatively impacted by a 2% decline in revenues to $1.85 billion. Premium revenues remained unchanged year-over-year, while net investment income rose 3%.

“Genworth’s recent achievements enable us to further refine our priorities to maximize long-term shareholder value by allocating capital from Enact, launching our CareScout services business, and stabilizing LTC through our multi-year rate action plan. As we continue to execute on our priorities, we will be well-positioned to continue returning capital to shareholders,” said Genworth’s CEO Tom McInerney.

Prior Performance

  • Genworth Financial Q4 2022 earnings infographic
  • Genworth Financial Q3 2022 earnings infographics

_________________________________________________________________________________________________________________

Stocks you may like:

Bank of America (BAC) Stock

Wells Fargo (WFC) Stock

JPMorgan Chase (JPM) Stock

Citigroup (C) Stock

Goldman Sachs (GS) Stock

Morgan Stanley (MS) Stock

_________________________________________________________________________________________________________________

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top